News
BMXMF
84.00
NaN%
--
UBS Keeps Their Buy Rating on bioMerieux (0RUG)
TipRanks · 6h ago
Weekly Report: what happened at BMXMF last week (0511-0515)?
Weekly Report · 3d ago
Weekly Report: what happened at BMXMF last week (0504-0508)?
Weekly Report · 05/11 09:30
Weekly Report: what happened at BMXMF last week (0427-0501)?
Weekly Report · 05/04 09:29
Weekly Report: what happened at BMXMF last week (0420-0424)?
Weekly Report · 04/27 09:30
Barclays Sticks to Its Hold Rating for bioMerieux (0RUG)
TipRanks · 04/25 01:25
bioMerieux price target lowered to EUR 71.60 from EUR 120.50 at JPMorgan
TipRanks · 04/24 17:00
bioMerieux downgraded to Hold from Buy at Deutsche Bank
TipRanks · 04/24 09:15
Weekly Report: what happened at BMXMF last week (0413-0417)?
Weekly Report · 04/20 09:29
bioMerieux price target lowered to EUR 100 from EUR 108 at Morgan Stanley
TipRanks · 04/14 14:46
bioMerieux (0RUG) Receives a Hold from Morgan Stanley
TipRanks · 04/14 12:40
Weekly Report: what happened at BMXMF last week (0406-0410)?
Weekly Report · 04/13 09:30
Weekly Report: what happened at BMXMF last week (0330-0403)?
Weekly Report · 04/06 09:30
Weekly Report: what happened at BMXMF last week (0323-0327)?
Weekly Report · 03/30 09:30
Weekly Report: what happened at BMXMF last week (0316-0320)?
Weekly Report · 03/23 09:29
Weekly Report: what happened at BMXMF last week (0309-0313)?
Weekly Report · 03/16 09:29
UBS Sticks to Their Buy Rating for bioMerieux (0RUG)
TipRanks · 03/11 10:05
Weekly Report: what happened at BMXMF last week (0302-0306)?
Weekly Report · 03/09 09:29
Weekly Report: what happened at BMXMF last week (0223-0227)?
Weekly Report · 03/02 09:29
bioMerieux price target lowered to EUR 100 from EUR 110 at Barclays
TipRanks · 02/24 17:05
More
Webull provides a variety of real-time BMXMF stock news. You can receive the latest news about Biomerieux through multiple platforms. This information may help you make smarter investment decisions.
About BMXMF
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.